China Medical Technologies to Participate Investor Conferences in March 2010

Monday, February 8, 2010 General News
Email Print This Page Comment
Font : A-A+

BEIJING, Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading

China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will participate at the following investor conferences in March 2010:



    Investor Conference 
Date Location Rodman & Renshaw Annual March 7-9, 2010 The Regent Hotel, China Investment Beijing Conference Credit Suisse Asian March 22-26, Conrad Hong Kong Investment Conference 2010 2010

The Company's Chief Financial Officer, Mr. Sam Tsang, will discuss the Company's strategies, operations, growth opportunities as well as its published financial results to date with institutional investors during the two investor conferences.

About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech.com .

    For more information, please contact:

     Winnie Yam
     Tel:   +852-2511-9808
     Email: IR@chinameditech.com

SOURCE China Medical Technologies, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook